477 related articles for article (PubMed ID: 16530578)
1. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Meggitt SJ; Gray JC; Reynolds NJ
Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
3. [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
Martel RM; Melwani P; Islas D; Peñate Y; Borrego L
Actas Dermosifiliogr; 2010 Jun; 101(5):415-20. PubMed ID: 20525484
[TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
Murphy LA; Atherton D
Br J Dermatol; 2002 Aug; 147(2):308-15. PubMed ID: 12174104
[TBL] [Abstract][Full Text] [Related]
5. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
6. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
7. Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity.
Wee JS; Marinaki A; Smith CH
BMJ; 2011 Mar; 342():d1417. PubMed ID: 21441287
[No Abstract] [Full Text] [Related]
8. Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency.
Murphy LA; Atherton DJ
Pediatr Dermatol; 2003; 20(6):531-4. PubMed ID: 14651577
[TBL] [Abstract][Full Text] [Related]
9. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
Berth-Jones J; Takwale A; Tan E; Barclay G; Agarwal S; Ahmed I; Hotchkiss K; Graham-Brown RA
Br J Dermatol; 2002 Aug; 147(2):324-30. PubMed ID: 12174106
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine.
Garritsen FM; van der Schaft J; Bruijnzeel-Koomen CAF; van Schaik RH; de Graaf M; van den Broek MPH; de Bruin-Weller MS
J Dermatolog Treat; 2018 Jun; 29(4):375-382. PubMed ID: 28914560
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Simpson EL; Sinclair R; Forman S; Wollenberg A; Aschoff R; Cork M; Bieber T; Thyssen JP; Yosipovitch G; Flohr C; Magnolo N; Maari C; Feeney C; Biswas P; Tatulych S; Valdez H; Rojo R
Lancet; 2020 Jul; 396(10246):255-266. PubMed ID: 32711801
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG
Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
Thaçi D; Simpson EL; Beck LA; Bieber T; Blauvelt A; Papp K; Soong W; Worm M; Szepietowski JC; Sofen H; Kawashima M; Wu R; Weinstein SP; Graham NM; Pirozzi G; Teper A; Sutherland ER; Mastey V; Stahl N; Yancopoulos GD; Ardeleanu M
Lancet; 2016 Jan; 387(10013):40-52. PubMed ID: 26454361
[TBL] [Abstract][Full Text] [Related]
18. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine for atopic dermatitis.
Meggitt SJ; Reynolds NJ
Clin Exp Dermatol; 2001 Jul; 26(5):369-75. PubMed ID: 11488818
[TBL] [Abstract][Full Text] [Related]
20. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
Guttman-Yassky E; Teixeira HD; Simpson EL; Papp KA; Pangan AL; Blauvelt A; Thaçi D; Chu CY; Hong HC; Katoh N; Paller AS; Calimlim B; Gu Y; Hu X; Liu M; Yang Y; Liu J; Tenorio AR; Chu AD; Irvine AD
Lancet; 2021 Jun; 397(10290):2151-2168. PubMed ID: 34023008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
